Inflammatory bowel disease and risk of adverse pregnancy outcomes

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Boyd, Heather A ^a   Basit, Saima ^a   Harpsøe, Maria C ^a   Wohlfahrt, Jan ^a   Jess, Tine ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; MESALAZINE; CORTICOSTEROID;

ABORTION; ADULT; ADVERSE OUTCOME; APGAR SCORE; ARTICLE; COHORT ANALYSIS; CONGENITAL MALFORMATION; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; HAZARD RATIO; HUMAN; INFANT; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RISK ASSESSMENT; RISK FACTOR; ULCERATIVE COLITIS; COMPLICATION; CONGENITAL ABNORMALITIES; DENMARK; INFLAMMATORY BOWEL DISEASES; NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; RISK;

ADRENAL CORTEX HORMONES; APGAR SCORE; COHORT STUDIES; CONGENITAL ABNORMALITIES; DENMARK; FEMALE; HUMANS; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; RISK;

EID: 84939220186     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129567     Document Type: Article

References (19)

1. van der Woude CJ, Kolacek S, Dotan I, Øresland T, Vermeire S, Munkholm P, et al. European evidence-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis. 2010; 4: 493-510. doi: 10.1016/j.crohns.2010.07.004 PMID: 21122553
2. Vermeire S, Carbonnel F, Coulie PG, Geenen V, Hazes JMW, Masson PL, et al. Management of inflammatory bowel disease in pregnancy. J Crohns Colitis. 2012; 6: 811-823. doi: 10.1016/j.crohns.2012.04. 009 PMID: 22595185
3. Bortoli A, Pedersen N, Duricova D, D'Inca R, Gionchetti P, Panelli MR, et al. Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Aliment Pharmacol Ther. 2011; 34: 724-734. doi: 10.1111/j.1365-2036.2011.04794.x PMID: 21815900
4. Ajslev TA, Sorensen TIA, Jess T. Maternal inflammatory bowel disease and offspring body size: a prospective cohort study. Inflamm Bowel Dis. 2012; 18: 709-717. doi: 10.1002/ibd.21780 PMID: 21618364
5. Olsen J, Melbye M, Olsen SF, Sørensen TI, Aaby P, Andersen AM, et al. The Danish National Birth Cohort-its background, structure and aim. Scand J Public Health. 2001; 29: 300-307. PMID: 11775787
6. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999; 46: 263-268. PMID: 10421985
7. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998; 45: 320-323. PMID: 9675544
8. Hegyi T, Carbone T, Anwar M, Ostfeld B, Hiatt M, Koons A, et al. The Apgar score and its components in the preterm infant. Pediatrics. 1998; 101: 77-81. PMID: 9417155
9. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007; 56: 830-837. PMID: 17185356
10. Stephansson O, Larsson H, Pedersen L, Kieler H, Granath F, Ludvigsson JF, et al. Crohn's disease in a risk factor for preterm birth. Clin Gastroenterol Hepatol. 2010; 8: 509-515. doi: 10.1016/j.cgh.2010. 02.014 PMID: 20202483
11. Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med. 2004; 15: 237-241. PMID: 15280131
12. Raatikainen K, Mustonen J, Pajala MO, Heikkinen M, Heinonen S. The effects of pre- and post-pregnancy inflammatory bowel disease diagnosis on birth outcomes. Aliment Pharmacol Ther. 2011; 33: 333-339. doi: 10.1111/j.1365-2036.2010.04538.x PMID: 21138456
13. Nørgård B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn's Disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol. 2007; 102: 1947-1954. PMID: 17573787
14. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol. 2002; 97: 641-648. PMID: 11926208
15. Nasef NA, Ferguson LR. inflammatory bowel disease and pregnancy: overlapping pathways. Transl Res. 2012; 160: 65-83. doi: 10.1016/j.trsl.2011.12.002 PMID: 22687963
16. Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract Res Clin Obstet Gynaecol. 2007; 21: 467-478. PMID: 17448730
17. Nørgård B, Puho E, Pedersen L, Czeizel AE, Sørensen HT. Risk of congenital abnormalities in children born to women with ulcerative colitis. Am J Gastroenterol. 2003; 98: 2006-2010. PMID: 14499779
18. Stephansson O, Larsson H, Pedersen L, Kieler H, Granath F, Ludvigsson JF, et al. Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden. Inflamm Bowel Dis. 2011; 17: 795-801. doi: 10.1002/ibd.21369 PMID: 20564537
19. Nyboe Andersen N, Pasternak B, Basit S, Andersson M, Svanström H, Caspersen S, et al. Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease. JAMA. 2014; 311: 2406-2413. doi: 10.1001/jama.2014.5613 PMID: 24938563